• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于递送小干扰RNA适配体嵌合体的通用蛋白标签。

A universal protein tag for delivery of SiRNA-aptamer chimeras.

作者信息

Liu Hong Yan, Gao Xiaohu

机构信息

Department of Bioengineering, University of Washington, Seattle, WA 98195, USA.

出版信息

Sci Rep. 2013 Nov 7;3:3129. doi: 10.1038/srep03129.

DOI:10.1038/srep03129
PMID:24196104
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3819613/
Abstract

siRNA-aptamer chimeras have emerged as one of the most promising approaches for targeted delivery of siRNA due to the modularity of their diblock RNA structure, relatively lower cost over other targeted delivery approaches, and, most importantly, the outstanding potential for clinical translation. However, additional challenges must be addressed for efficient RNA interference (RNAi), in particular, endosomal escape. Currently, vast majority of siRNA delivery vehicles are based on cationic materials, which form complexes with negatively charged siRNA. Unfortunately, these approaches complicate the formulations again by forming large complexes with heterogeneous sizes, unfavorable surface charges, colloidal instability, and poor targeting ligand orientation. Here, we report the development of a small and simple protein tag that complements the therapeutic and targeting functionalities of chimera with two functional domains: a dsRNA binding domain (dsRBD) for siRNA docking and a pH-dependent polyhistidine to disrupt endosomal membrane. The protein selectively tags along the siRNA block of individual chimera, rendering the overall size of the complex small, desirable for deep tissue penetration, and the aptamer block accessible for target recognition. More interestingly, we found that extending the c-terminal polyhistidine segment in the protein tag to 18 amino acids completely abolishes the RNA binding function of dsRBD.

摘要

由于其双嵌段RNA结构的模块化、相对于其他靶向递送方法较低的成本,以及最重要的是其在临床转化方面的巨大潜力,小干扰RNA适配体嵌合体已成为小干扰RNA靶向递送最有前景的方法之一。然而,要实现高效的RNA干扰(RNAi),尤其是内体逃逸,还必须应对其他挑战。目前,绝大多数小干扰RNA递送载体基于阳离子材料,这些材料与带负电荷的小干扰RNA形成复合物。不幸的是,这些方法又使制剂变得复杂,因为会形成大小不均一、表面电荷不利、胶体不稳定且靶向配体取向不佳的大复合物。在此,我们报告了一种小而简单的蛋白质标签的开发,该标签通过两个功能域补充了嵌合体的治疗和靶向功能:一个用于小干扰RNA对接的双链RNA结合域(dsRBD)和一个用于破坏内体膜的pH依赖性多组氨酸。该蛋白质沿着单个嵌合体的小干扰RNA区段选择性标记,使复合物的整体尺寸变小,有利于深入组织渗透,且使适配体区段可用于靶标识别。更有趣的是,我们发现将蛋白质标签中的c末端多组氨酸区段延长至18个氨基酸会完全消除dsRBD的RNA结合功能。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fa3/3819613/e53e36d81c53/srep03129-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fa3/3819613/6b3ad5a594dd/srep03129-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fa3/3819613/e7d0ed539fce/srep03129-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fa3/3819613/f88cb99054aa/srep03129-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fa3/3819613/33e65509941a/srep03129-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fa3/3819613/e53e36d81c53/srep03129-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fa3/3819613/6b3ad5a594dd/srep03129-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fa3/3819613/e7d0ed539fce/srep03129-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fa3/3819613/f88cb99054aa/srep03129-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fa3/3819613/33e65509941a/srep03129-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fa3/3819613/e53e36d81c53/srep03129-f5.jpg

相似文献

1
A universal protein tag for delivery of SiRNA-aptamer chimeras.用于递送小干扰RNA适配体嵌合体的通用蛋白标签。
Sci Rep. 2013 Nov 7;3:3129. doi: 10.1038/srep03129.
2
siRNA-aptamer chimeras on nanoparticles: preserving targeting functionality for effective gene silencing.纳米颗粒上的 siRNA-aptamer 嵌合体:保留靶向功能以实现有效的基因沉默。
ACS Nano. 2011 Oct 25;5(10):8131-9. doi: 10.1021/nn202772p. Epub 2011 Sep 21.
3
Cell type-specific delivery of siRNAs with aptamer-siRNA chimeras.利用适配体-小干扰RNA嵌合体实现细胞类型特异性的小干扰RNA递送。
Nat Biotechnol. 2006 Aug;24(8):1005-15. doi: 10.1038/nbt1223. Epub 2006 Jun 25.
4
Cell-specific induction of apoptosis by rationally designed bivalent aptamer-siRNA transcripts silencing eukaryotic elongation factor 2.通过合理设计的二价适体-siRNA转录本沉默真核生物延伸因子2实现细胞特异性凋亡诱导。
Curr Cancer Drug Targets. 2008 Nov;8(7):554-65. doi: 10.2174/156800908786241078.
5
Development of cell-type specific anti-HIV gp120 aptamers for siRNA delivery.用于小干扰RNA递送的细胞类型特异性抗HIV gp120适配体的研发。
J Vis Exp. 2011 Jun 23(52):2954. doi: 10.3791/2954.
6
Highly efficient delivery of siRNA to a heart transplant model by a novel cell penetrating peptide-dsRNA binding domain.新型细胞穿透肽-dsRNA 结合域高效递送至心脏移植模型的 siRNA。
Int J Pharm. 2014 Jul 20;469(1):206-13. doi: 10.1016/j.ijpharm.2014.04.050. Epub 2014 Apr 23.
7
Targeted siRNA delivery using aptamer-siRNA chimeras and aptamer-conjugated nanoparticles.靶向 siRNA 递呈的适体-siRNA 嵌合体和适体偶联纳米颗粒。
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2019 May;11(3):e1543. doi: 10.1002/wnan.1543. Epub 2018 Aug 2.
8
Systemic Administration and Targeted Radiosensitization via Chemically Synthetic Aptamer-siRNA Chimeras in Human Tumor Xenografts.通过化学合成的适体-siRNA嵌合体在人肿瘤异种移植模型中的全身给药和靶向放射增敏作用
Mol Cancer Ther. 2015 Dec;14(12):2797-804. doi: 10.1158/1535-7163.MCT-15-0291-T. Epub 2015 Oct 5.
9
Gene Knockdown by EpCAM Aptamer-siRNA Chimeras Suppresses Epithelial Breast Cancers and Their Tumor-Initiating Cells.EpCAM适配体-siRNA嵌合体介导的基因敲低可抑制乳腺上皮癌及其肿瘤起始细胞
Mol Cancer Ther. 2015 Oct;14(10):2279-91. doi: 10.1158/1535-7163.MCT-15-0201-T. Epub 2015 Aug 11.
10
Systemic administration of optimized aptamer-siRNA chimeras promotes regression of PSMA-expressing tumors.优化的适体-小干扰RNA嵌合体的全身给药促进表达前列腺特异性膜抗原(PSMA)的肿瘤消退。
Nat Biotechnol. 2009 Sep;27(9):839-49. doi: 10.1038/nbt.1560. Epub 2009 Aug 23.

引用本文的文献

1
Non-Cationic RGD-Containing Protein Nanocarrier for Tumor-Targeted siRNA Delivery.用于肿瘤靶向性siRNA递送的含非阳离子RGD的蛋白质纳米载体
Pharmaceutics. 2021 Dec 17;13(12):2182. doi: 10.3390/pharmaceutics13122182.
2
The Multifaceted Histidine-Based Carriers for Nucleic Acid Delivery: Advances and Challenges.基于组氨酸的多功能核酸递送载体:进展与挑战
Pharmaceutics. 2020 Aug 14;12(8):774. doi: 10.3390/pharmaceutics12080774.
3
Peptide carriers to the rescue: overcoming the barriers to siRNA delivery for cancer treatment.肽载体来救援:克服用于癌症治疗的 siRNA 递释的障碍。

本文引用的文献

1
Quantum dots as a platform for nanoparticle drug delivery vehicle design.量子点作为纳米药物传递载体设计的平台。
Adv Drug Deliv Rev. 2013 May;65(5):703-18. doi: 10.1016/j.addr.2012.09.036. Epub 2012 Sep 20.
2
Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size.小于 100nm 的聚合物胶束在通透性差的肿瘤中的积累取决于粒径大小。
Nat Nanotechnol. 2011 Oct 23;6(12):815-23. doi: 10.1038/nnano.2011.166.
3
siRNA-aptamer chimeras on nanoparticles: preserving targeting functionality for effective gene silencing.
Transl Res. 2019 Dec;214:92-104. doi: 10.1016/j.trsl.2019.07.010. Epub 2019 Jul 29.
4
Aptamers as Therapeutic Agents: Has the Initial Euphoria Subsided?适体作为治疗剂:最初的兴奋是否已经消退?
Mol Diagn Ther. 2019 Jun;23(3):301-309. doi: 10.1007/s40291-019-00400-6.
5
A ribonucleoprotein octamer for targeted siRNA delivery.一种用于靶向递送小干扰RNA的核糖核蛋白八聚体。
Nat Biomed Eng. 2018 May;2(5):326-337. doi: 10.1038/s41551-018-0214-1. Epub 2018 Apr 2.
6
Aptamer-based targeted therapy.基于适配体的靶向治疗。
Adv Drug Deliv Rev. 2018 Sep;134:65-78. doi: 10.1016/j.addr.2018.08.005. Epub 2018 Aug 17.
7
Gene Encodes a Cell-Penetrating Protein That Interacts With the CSN5 Subunit of the COP9 Signalosome.基因编码一种与COP9信号体的CSN5亚基相互作用的细胞穿透蛋白。
Front Plant Sci. 2018 Jun 26;9:904. doi: 10.3389/fpls.2018.00904. eCollection 2018.
8
Aptamers: Uptake mechanisms and intracellular applications.适配体:摄取机制和细胞内应用。
Adv Drug Deliv Rev. 2018 Sep;134:22-35. doi: 10.1016/j.addr.2018.07.003. Epub 2018 Jul 6.
9
Targeted Delivery of siRNA Therapeutics to Malignant Tumors.将小干扰RNA治疗药物靶向递送至恶性肿瘤
J Drug Deliv. 2017;2017:6971297. doi: 10.1155/2017/6971297. Epub 2017 Nov 9.
10
Nucleic Acid Aptamers: Emerging Applications in Medical Imaging, Nanotechnology, Neurosciences, and Drug Delivery.核酸适体:在医学成像、纳米技术、神经科学和药物输送中的新兴应用。
Int J Mol Sci. 2017 Nov 16;18(11):2430. doi: 10.3390/ijms18112430.
纳米颗粒上的 siRNA-aptamer 嵌合体:保留靶向功能以实现有效的基因沉默。
ACS Nano. 2011 Oct 25;5(10):8131-9. doi: 10.1021/nn202772p. Epub 2011 Sep 21.
4
Engineered design of mesoporous silica nanoparticles to deliver doxorubicin and P-glycoprotein siRNA to overcome drug resistance in a cancer cell line.介孔二氧化硅纳米粒子的工程设计,以递送阿霉素和 P-糖蛋白 siRNA,以克服癌细胞系中的药物耐药性。
ACS Nano. 2010 Aug 24;4(8):4539-50. doi: 10.1021/nn100690m.
5
Polyethyleneimine coating enhances the cellular uptake of mesoporous silica nanoparticles and allows safe delivery of siRNA and DNA constructs.聚乙烯亚胺涂层可增强介孔硅纳米粒子的细胞摄取能力,并能安全递送 siRNA 和 DNA 构建体。
ACS Nano. 2009 Oct 27;3(10):3273-86. doi: 10.1021/nn900918w.
6
Systemic administration of optimized aptamer-siRNA chimeras promotes regression of PSMA-expressing tumors.优化的适体-小干扰RNA嵌合体的全身给药促进表达前列腺特异性膜抗原(PSMA)的肿瘤消退。
Nat Biotechnol. 2009 Sep;27(9):839-49. doi: 10.1038/nbt.1560. Epub 2009 Aug 23.
7
Intracellular small interfering RNA delivery using genetically engineered double-stranded RNA binding protein domain.利用基因工程双链RNA结合蛋白结构域进行细胞内小分子干扰RNA递送
J Gene Med. 2009 Sep;11(9):804-12. doi: 10.1002/jgm.1365.
8
Chemical vectors for gene delivery: a current review on polymers, peptides and lipids containing histidine or imidazole as nucleic acids carriers.用于基因递送的化学载体:关于含组氨酸或咪唑的聚合物、肽和脂质作为核酸载体的当前综述。
Br J Pharmacol. 2009 May;157(2):166-78. doi: 10.1111/j.1476-5381.2009.00288.x.
9
Efficient siRNA delivery into primary cells by a peptide transduction domain-dsRNA binding domain fusion protein.通过肽转导结构域 - dsRNA结合结构域融合蛋白将小干扰RNA高效递送至原代细胞。
Nat Biotechnol. 2009 Jun;27(6):567-71. doi: 10.1038/nbt.1541. Epub 2009 May 17.
10
Layer-by-layer assembled gold nanoparticles for siRNA delivery.用于小干扰RNA递送的逐层组装金纳米颗粒。
Nano Lett. 2009 May;9(5):2059-64. doi: 10.1021/nl9003865.